Literature DB >> 10397688

Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity.

A B Zaltsman1, S J George, A C Newby.   

Abstract

The balance between matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) plays an important role in extracellular matrix turnover and thereby modulates atherosclerotic plaque development. MMP-1, -2, -3, and -9 activity is increased by atherosclerosis, but the status of TIMPs is less clear. We therefore compared secretion of TIMPs-1 and -2 from cultured aortic explants derived from arch, middle, and distal portions of thoracic aortas of normal rabbits and rabbits fed a 1% cholesterol diet for 8 weeks, using reverse zymography of conditioned media. Cholesterol feeding significantly increased secretion of TIMP-1 from arch and middle portions (both 2.6-fold), accompanied by 2.0- and 2.7-fold increases in TIMP-2, respectively. Atherosclerotic aortas exhibited increased immunoreactive TIMP-1 and TIMP-2 in endothelial cells, smooth muscle cells, and macrophages. Staining of extracellular matrix was also prominent within the noncellular boundary region between fibrous cap and the lipid core, and within the lipid core. Increased TIMP-2 staining was also found in the media subjacent to the lipid core. In situ gelatin zymography demonstrated excess MMP activity within the plaque with partial inhibition in the lipid core base and subjacent media, consistent with the distribution of TIMPs. Casein zymography and in situ zymography demonstrated that increased caseinolytic activity was confined to the pericellular zones of macrophages within the lipid core, again consistent with its restriction by TIMPs. In summary, atherosclerosis increases TIMP expression, which counterbalances, in part, increased MMP activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397688     DOI: 10.1161/01.atv.19.7.1700

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.

Authors:  Tatiane C Izidoro-Toledo; Danielle A Guimaraes; Vanessa A Belo; Raquel F Gerlach; Jose Eduardo Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

2.  Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.

Authors:  Cory M Yamashita; Lior Dolgonos; Rachel L Zemans; Scott K Young; Jennifer Robertson; Natalie Briones; Tomoko Suzuki; Megan N Campbell; Jack Gauldie; Derek C Radisky; David W H Riches; Guoying Yu; Naftali Kaminski; Christopher A G McCulloch; Gregory P Downey
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

Review 3.  Current, new and future treatments in dyslipidaemia and atherosclerosis.

Authors:  P H Chong; B S Bachenheimer
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

4.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

Authors:  M P Herman; G K Sukhova; W Kisiel; D Foster; M R Kehry; P Libby; U Schönbeck
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

5.  Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages.

Authors:  Jason L Johnson; Graciela B Sala-Newby; Yasmin Ismail; Concepción M Aguilera; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

6.  Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases.

Authors:  Micha F Dorsch; Jenny A Barrett; Richard A Lawrance; Azhar Maqbool; Nigel P Durham; Stacey Ellis; Nilesh J Samani; Tim Bishop; Stephen G Ball; Anthony J Balmforth; Alistair S Hall
Journal:  J Hum Genet       Date:  2003-09-19       Impact factor: 3.172

7.  Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease.

Authors:  Nitin Mahajan; Namita Malik; Ajay Bahl; Yashpaul Sharma; Veena Dhawan
Journal:  Mol Cell Biochem       Date:  2009-05-02       Impact factor: 3.396

8.  Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages.

Authors:  Yao Yiqin; Xie Meilin; Xue Jie; Zhang Keping
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

9.  Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells.

Authors:  Ulisse Garbin; Anna Fratta Pasini; Chiara Stranieri; Stefania Manfro; Chiara Mozzini; Veronica Boccioletti; Andrea Pasini; Mattia Cominacini; Stefano Evangelista; Luciano Cominacini
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

10.  Cholesterol diet withdrawal leads to an initial plaque instability and subsequent regression of accelerated iliac artery atherosclerosis in rabbits.

Authors:  Vivek Khanna; Manish Jain; Vishal Singh; Jitendra S Kanshana; Prem Prakash; Manoj K Barthwal; Puvvada S R Murthy; Madhu Dikshit
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.